These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


310 related items for PubMed ID: 16245791

  • 1. [A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
    Fujiwara K.
    Kekkaku; 2005 Sep; 80(9):601-5. PubMed ID: 16245791
    [Abstract] [Full Text] [Related]

  • 2. [Mycobacterium intracellulare lung disease that was detected by follow-up after pulmonary resection for lung cancer; report of a case].
    Fujiwara K.
    Kyobu Geka; 2007 Aug; 60(9):861-4. PubMed ID: 17703629
    [Abstract] [Full Text] [Related]

  • 3. [A case of Mycobacterium avium complex pulmonary disease in the early phase].
    Tanaka E, Taniguchi M, Yuba Y, Hashimoto T, Amitani R, Kuze F.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):68-72. PubMed ID: 8114376
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [Abstract] [Full Text] [Related]

  • 5. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E.
    Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
    [No Abstract] [Full Text] [Related]

  • 6. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
    Faruqi S, Kastelik JA, McGivern DV.
    Eur J Intern Med; 2008 May; 19(3):216-8. PubMed ID: 18395168
    [Abstract] [Full Text] [Related]

  • 8. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K, Ebe T.
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

  • 10. [Case of pulmonary mycobacterium avium complex disease, showing hypersensitivity pneumonitis-like diffuse shadow].
    Ohashi R, Akagawa S, Kurashima A, Tsuchiya K, Miyamoto M, Masuda K, Tamura A, Nagai H, Nagayama N, Kawabe Y, Machida K, Yotsumoto H, Hebisawa A.
    Kekkaku; 2006 Jan 15; 81(1):19-23. PubMed ID: 16479997
    [Abstract] [Full Text] [Related]

  • 11. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 12. [A case of Mycobacterium intracellulare infection with chronic empyema].
    Taniguchi H, Izumi S.
    Kekkaku; 2006 Jun 01; 81(6):425-8. PubMed ID: 16838681
    [Abstract] [Full Text] [Related]

  • 13. Two faces of MAC-induced lung disease.
    Tetenta S, Abunasser J, Bandyopadhyay T.
    Conn Med; 2008 Apr 01; 72(4):203-5. PubMed ID: 18478985
    [Abstract] [Full Text] [Related]

  • 14. [Perspective of pulmonary MAC infection treatment].
    Kurashima A.
    Kekkaku; 2007 Mar 01; 82(3):195-9. PubMed ID: 17444124
    [Abstract] [Full Text] [Related]

  • 15. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y, Oka M.
    Kekkaku; 2008 Dec 01; 83(12):779-84. PubMed ID: 19172823
    [Abstract] [Full Text] [Related]

  • 16. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 01; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 17. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
    Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, Ogawa K, Inoue Y.
    BMJ Open Respir Res; 2019 Jul 01; 6(1):e000434. PubMed ID: 31258920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnosis and treatment of infections due to Mycobacterium avium complex.
    Kasperbauer SH, Daley CL.
    Semin Respir Crit Care Med; 2008 Oct 01; 29(5):569-76. PubMed ID: 18810690
    [Abstract] [Full Text] [Related]

  • 20. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.